We planned to investigate the role of the CCR2/MCP-1 pathway in MDSC-associated tumor progression in murine syngeneic lung cancer models but undertook some basic characterization of the main mouse strain to be used, namely mice lacking the gene for CCR2 (CCR2KO). The gene discussed is CCR2; the disease is lung carcinoma.